807
Views
9
CrossRef citations to date
0
Altmetric
Original Article

The “Aging Males’ Symptoms” Scale (AMS): predictive value for lowered circulating androgens

, , , , &
Pages 253-257 | Received 25 Jul 2012, Accepted 09 Sep 2012, Published online: 19 Oct 2012

References

  • Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–598.
  • Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp 1997;46:410–413.
  • Lapauw B, Goemaere S, Zmierczak H, Van Pottelbergh I, Mahmoud A, Taes Y, De Bacquer D, et al. The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes. Eur J Endocrinol 2008;159:459–468.
  • Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995;4:735–741.
  • Blümel JE, Chedraui P, Gili SA, Navarro A, Valenzuela K, Vallejo S. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men? Maturitas 2009;63:365–368.
  • Keenan DM, Takahashi PY, Liu PY, Roebuck PD, Nehra AX, Iranmanesh A, Veldhuis JD. An ensemble model of the male gonadal axis: illustrative application in aging men. Endocrinology 2006;147:2817–2828.
  • Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–2559.
  • Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12.
  • Spetz Holm AC, Fredrikson MG, Hammar ML. Symptoms of testosterone deficiency in early middle aged men. Aging Male 2012;15:78–84.
  • Yassin AA, Saad F. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med 2007;4:497–501.
  • Auyeung TW, Lee JS, Kwok T, Leung J, Ohlsson C, Vandenput L, Leung PC, Woo J. Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. Eur J Endocrinol 2011;164:811–817.
  • LeBlanc ES, Wang PY, Lee CG, Barrett-Connor E, Cauley JA, Hoffman AR, Laughlin GA, et al. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab 2011;96:3855–3863.
  • Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci (Regul Ed) 2006;10:77–82.
  • Seidman SN, Araujo AB, Roose SP, Devanand DP, Xie S, Cooper TB, McKinlay JB. Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry 2002;159:456–459.
  • Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W. A new ‘Aging Males’ Symptoms’ Rating Scale. The Aging Male 1999;2:105–114.
  • Rosen RC, Araujo AB, Connor MK, Elstad EA, McGraw SA, Guay AT, Morgentaler A, Miner MM. Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls. Aging Male 2009;12:77–85.
  • Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, et al. The Aging Males’ Symptoms (AMS) Scale: review of its methodological characteristics. Health Qual Life Outcomes 2003;1:77.
  • Valenti G, Gontero P, Saccò M, Fontana F, Strollo F, Castellucci A, Heinemann LA. Harmonized Italian version of the Aging Males’ Symptoms Scale. Aging Male 2005;8:180–183.
  • Rabah DM, Altaweel W, Arafa MA. Clinical assessment and validation of an Arabic Aging Male Symptoms questionnaire in patients with androgen deficiency. Aging Male 2011;14:33–36.
  • Akinyemi A, Bamiwuye O, Inathaniel T, Ijadunola K, Fatusi A. The Nigerian Aging Males’ Symptoms Scale. Experience in elderly males. Aging Male 2008;11:89–93.
  • Leungwattanakij S, Lersithichai P, Ratana-Olarn K. The Aging Males’ Symptoms Rating Scale: cultural and linguistic validation into Thai. J Med Assoc Thai 2003;86:1106–1115.
  • Conway K, Heinemann LA, Giroudet C, Johannes EJ, Myon E, Taieb C, Raynaud JP. Harmonized French version of the Aging Males’ Symptoms Scale. Aging Male 2003;6:106–109.
  • Miwa Y, Kaneda T, Yokoyama O. Correlation between the Aging Males’ Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006;3:723–726.
  • Kang J 2nd, Ham BK, Oh MM, Kim JJ, Moon du G. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean J Urol 2011;52:416–420.
  • T’Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004;29:201–214.
  • Morley JE, Perry HM 3rd, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006;53:424–429.
  • Clapauch R, Braga DJ, Marinheiro LP, Buksman S, Schrank Y. Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires. Arq Bras Endocrinol Metabol 2008;52:1439–1447.
  • Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–3672.
  • St Sauver JL, Jacobson DJ, McGree ME, Girman CJ, Klee GG, Lieber MM, Jacobsen SJ. Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes. Am J Epidemiol 2011;173:787–796.
  • Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;147:750–754.
  • Beutel ME, Wiltink J, Hauck EW, Auch D, Behre HM, Brähler E, Weidner W; Hypogonadism Investigator Group. Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 2005;47:749–755.
  • Basar MM, Aydin G, Mert HC, Keles I, Caglayan O, Orkun S, Batislam E. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology 2005;66:597–601.
  • Ahn HS, Park CM, Lee SW. The clinical relevance of sex hormone levels and sexual activity in the ageing male. BJU Int 2002;89:526–530.
  • Yavuz BB, Ozkayar N, Halil M, Cankurtaran M, Ulger Z, Tezcan E, Gurlek A, Ariogul S. Free testosterone levels and implications on clinical outcomes in elderly men. Aging Clin Exp Res 2008;20:201–206.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.